Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
KalVista Pharmaceuticals (4XC1.XETRA) Q2 2026 Earnings
4XC1.XETRA
14
May
Confirmed
Q2 2026
-0.35
-0.02
0.32
0.65
Details
Expected EPS
-0.35006388089999996
Actual EPS
N/A
Surprise EPS
0.35
Surprise Percent
+100%
Description
KalVista Pharmaceuticals (4XC1.XETRA) will report earnings of for Q2 2026 on May 14, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login